LTRN·51654W101·US·equity·Healthcare - Biotechnology-Activist
LTRN (LANTERN PHARMA INC) is held by 21 institutional investors as of Q1 2026. Largest holders: RENAISSANCE TECHNOLOGIES LLC ($158,920), GEODE CAPITAL MANAGEMENT, LLC ($152,984), BlackRock, Inc. ($62,016). Net institutional sentiment: Mixed.
See how LTRN's score breaks down across 4 SEC sources
Showing 1-20 of 25
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer